New Enterprise Associates, Inc. is a private equity and venture capital firm established in 1977 and headquartered in Menlo Park, California, with additional offices in India and China. The firm specializes in investments across various stages of company development, including seed, start-up, early stage, and later stage, with a focus on sectors such as information technology, healthcare, and energy technology. NEA's investment strategy encompasses a wide range of industries, including consumer internet, software, biotechnology, medical devices, and alternative energy. With over $19 billion in cumulative committed capital, the firm has a notable track record, having participated in more than 210 portfolio company IPOs and over 360 acquisitions. NEA aims to invest between $0.05 million and $20 million, targeting both domestic and international markets, particularly in Asia and the Americas.
Fire1, based in Dublin, Ireland, is dedicated to developing innovative therapeutic devices aimed at enhancing the lives of heart failure patients. The company has created a remote monitoring system that allows healthcare providers to access real-time patient data and insights. This technology facilitates the early detection of complications associated with heart failure, enabling proactive interventions that can lead to improved patient outcomes. Through its focus on remote monitoring, Fire1 seeks to address critical challenges in heart failure management and contribute to better healthcare solutions.
Segment.io, Inc. is a company that specializes in customer data infrastructure, enabling businesses to collect, unify, and connect their customer data across various platforms. Founded in 2011 and headquartered in San Francisco, California, Segment offers a single API that allows organizations to track customer information across multiple devices and channels. This data can be seamlessly sent to a variety of third-party tools, internal systems, or SQL databases. Additionally, Segment provides a product known as Data Lakes, which assists companies in leveraging their customer data to enhance user experiences. The company also maintains an office in Dublin, Ireland, and operates as a subsidiary of Twilio Inc. as of November 2020.
Fire1, based in Dublin, Ireland, is dedicated to developing innovative therapeutic devices aimed at enhancing the lives of heart failure patients. The company has created a remote monitoring system that allows healthcare providers to access real-time patient data and insights. This technology facilitates the early detection of complications associated with heart failure, enabling proactive interventions that can lead to improved patient outcomes. Through its focus on remote monitoring, Fire1 seeks to address critical challenges in heart failure management and contribute to better healthcare solutions.
Strongbridge Biopharma’s primary focus has been to build its franchise around rare endocrine disorders, which includes product candidates for the treatment of endogenous Cushing’s syndrome and acromegaly, two rare diseases with a high unmet need for innovative treatment options. Given the well-identified and concentrated prescriber base addressing its target markets, the Company intends to use a small, focused sales force to market its products, if approved, in the United States, European Union and other key global markets. The Company intends to identify and in-license or acquire products or product candidates that would be complementary to its existing rare endocrine franchise or that would form the basis for new rare disease franchises.
Fire1, based in Dublin, Ireland, is dedicated to developing innovative therapeutic devices aimed at enhancing the lives of heart failure patients. The company has created a remote monitoring system that allows healthcare providers to access real-time patient data and insights. This technology facilitates the early detection of complications associated with heart failure, enabling proactive interventions that can lead to improved patient outcomes. Through its focus on remote monitoring, Fire1 seeks to address critical challenges in heart failure management and contribute to better healthcare solutions.
Segment.io, Inc. is a company that specializes in customer data infrastructure, enabling businesses to collect, unify, and connect their customer data across various platforms. Founded in 2011 and headquartered in San Francisco, California, Segment offers a single API that allows organizations to track customer information across multiple devices and channels. This data can be seamlessly sent to a variety of third-party tools, internal systems, or SQL databases. Additionally, Segment provides a product known as Data Lakes, which assists companies in leveraging their customer data to enhance user experiences. The company also maintains an office in Dublin, Ireland, and operates as a subsidiary of Twilio Inc. as of November 2020.
Forcepoint LLC is a cybersecurity company that provides software solutions to protect users, data, and networks from insider threats and external attacks across various sectors, including financial services, healthcare, government, and public safety. The company's offerings include the TRITON APX Suite for integrated content security management, TRITON AP-EMAIL and TRITON AP-WEB for advanced threat protection, and TRITON AP-DATA and TRITON AP-ENDPOINT for insider threat monitoring and data security. Forcepoint also delivers cloud security solutions, such as TRITON AP-EMAIL Cloud and TRITON AP-WEB Cloud, to ensure safe communication and web access for users regardless of location. Additionally, the company provides network security through its Stonesoft NGFW and advanced analytics with SureView Analytics. Forcepoint's services extend to data security consulting, cybersecurity intelligence, and technical training. Founded in 2015 and based in Austin, Texas, with a center in Cork, Ireland, Forcepoint operates as a subsidiary of Raytheon Company, having formerly been known as Raytheon|Websense.